EN DE
Watch Chiron Real Estate Inc. for free: we tell you when fair value or trend changes.
Data-driven stock valuation

Chiron Real Estate Inc. (XRN) fair value: what the stock is really worth

As of Nov 6, 2026: fair value (intrinsic value) of Chiron Real Estate Inc. stock $71.75, price $28.70, upside +150.0%, quality 42 out of 100. Rating: strongly undervalued. Calculated from audited financials with 4 of our 26 valuation models and 37 quality factors, updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Real Estate US

CR Chiron Real Estate Inc. logo Some data Nov 7, 2026

Chiron Real Estate Inc.

XRN · US
Cheap, value-trap risk

The stock costs 60% less than our calculation considers fair.

Fair value $71.75 · Strongly undervalued
Highly profitable · 36.7% net margin (TTM)
Low debt
Ranks above peers (10/14)
Even on cautious assumptions the value is 53% above the price ($44.01).
Quality 42/100
Expensive Growth (revenue 5y +11.5 %/yr in USD)
7.0% dividend yield · Watch coverage
Moderate moat 48/100 · thin data
Insiders bought $3.2M (6M)
Some data
Negative free cash flow
Watch Chiron Real Estate Inc. for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

$63.01 $25.88 Fair Value $71.75 Aug 2021 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 7, 2026.

How to read this chart

60‑month range $25.88 – $63.01 · fair‑value band $44.01 – $99.49 · the $28.70 price screens below the $71.75 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 7, 2026.

Follow Chiron Real Estate in your weekly email

Every Wednesday you see whether Chiron Real Estate is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Chiron Real Estate Inc. is a net-lease medical REIT that acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems. Chiron Real Estate Inc. was established on March 18, 2011, incorporated in Maryland and is based in Bethesda, Maryland.

Stock analysis

Chiron Real Estate Inc. (XRN) currently trades at $28.70, while our model-based Fair Value estimate is $71.75, implying the stock looks roughly 60% undervalued today.

Show more

Valuation

Bull case: the Multiples group reads highest at a median of $61.39 per share, and 2 of the 3 models we run sit above the $28.70 price.

Bear case: the Asset-Based group reads lowest at $23.14, and 1 of the 3 models stay below the price. Data coverage for this calculation is medium.

Scenario range: $44.01 (bear) to $99.49 (bull), the price of $28.70 sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 42/100 (below-average quality), in the Real Estate sector.

Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.

Chiron Real Estate Inc. reported revenue of $161M in FY2025 versus $116M in FY2021, a compound +8.6%/yr. Reported net income was −$5.8M in FY2025.

Key figures

Market cap $416M Small · P/E ratio 8.2 · P/S ratio 2.65 · EPS (TTM) $3.50 · Dividend yield 7.0% · Net margin 36.7% · Return on equity 10.5% · Return on assets (EBIT) 3.1% (5-year average).

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 48 out of 100 (low confidence).

What moves the price

The share trades about 25% below its 52-week high and at its 52-week low, currently below its 200-day average.

For context, the median of 10 Real Estate peers we cover trades at −19% fair-value upside, at 150%, XRN screens cheaper than that median.

Fair Value models

Bear $44.01 Fair Value $71.75 Bull $99.49
Price $28.70 · Upside +150.0%
Capped: our models arrive at a very high value here. We deliberately show a more cautious Fair Value.
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2025 figures (about 10 months old). Earnings retained since then ($1.28 per share) are deliberately not added. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
EV/EBITDA $55.18 $89.96 $124.74 66
EV/EBIT $12.32 $32.82 $53.32 61
NCAV (Graham) $17.27 $23.14 $34.54 54
All 4 models by family
Multiples
EV/EBIT $12.32 $32.82 $53.32 61
EV/EBITDA $55.18 $89.96 $124.74 66
EV/Revenue n/a n/a $13.81 50
Asset-Based
NCAV (Graham) $17.27 $23.14 $34.54 54

Open the full fair value analysis →

Quality Score breakdown

Overall quality 42/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 6
How much profit the company makes from its sales and capital
Quality Growth 34
Are margins and returns getting better?
Cashflow 33
Do the profits arrive as real cash?
Financial strength 27
Debt, balance sheet and risk of trouble
Investment 67
Does it invest with discipline instead of growing at any price?
Low Volatility 59
How calm the share price moves, does not count
Price momentum 30
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 14
Distance to the 52-week high, does not count
New shares 86
Buys back shares or issues new ones?

Open the full quality analysis →

Insider trades

In the last 6 months, 12 officers or directors bought shares worth $3.2M, most recently on Aug 17, 2026. Buying cluster

  • BuyMatthew Fitzsimmons WhitlockChief Investment Officer1,000 shares at $36.80$36,795Aug 17, 2026
  • BuyAaron Robert RosethCOO, Director13,500 shares at $36.73$495,855Aug 12, 2026
  • BuyCharles FitzgeraldDirector2× since Aug 10, 2026: 41,600 shares, avg. $35.89$1.5MAug 11, 2026
  • BuyMark Okey Decker JrCEO and President, Director6× since Nov 14, 2025: 40,425 shares, avg. $34.00$1.4MAug 11, 2026
  • BuyMatthew CypherDirector1,420 shares at $35.12$49,870May 14, 2026
  • BuyJamie Allen BarberGeneral Counsel and Secretary1,481 shares at $33.50$49,614May 12, 2026
  • BuyRonald MarstonDirector1,500 shares at $34.07$51,112May 12, 2026
  • BuyLori WittmanDirector2,940 shares at $33.85$99,519May 12, 2026
  • BuyDanica HolleyCOO1,490 shares at $33.99$50,645May 12, 2026
  • BuyRobert J KiernanCFO and Treasurer2× since Nov 14, 2025: 6,000 shares, avg. $32.70$196,200May 11, 2026

Plus 2 more entries from the last 12 months.

Sales are often planned (taxes, diversification, 10b5-1 plans). Purchases with their own money are seen as the stronger sign. For information only: not part of the quality score or Fair Value.

Source: SEC Form 4, as of Nov 6, 2026. All filings at the SEC ↗

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 51/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Revenue growth 1 year
+16.3%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+5.5%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+11.5%
Start year 2020 (pandemic). Over 10 years: +54.6% a year
Revenue growth 11 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+73.3%
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
70.6% (2019) → 30.7% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
not computed

Watch XRN, get fair value alerts →

Compare Chiron Real Estate Inc. with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.REIT - Healthcare Facilities · 25 stocks

Beats the industry median on 10/14 measures
Overall it ranks above its industry peers.
Valuation
Quality Score 42 · Bottom 25%
Fair Value upside +150.0% · Top 25%
Profitability
Return on equity (12 months) 10.5% · Above median
Return on assets −0.5% · Bottom 25%
Net margin (12 months) 36.7% · Above median
Operating margin (12 months) 6.9% · Bottom 25%
Growth and dividend
Revenue growth (quarter YoY) 9.8% · Above median
Dividend yield (12 months) 7.0% · Above median
Balance sheet
Debt / equity 0.00× · Lowest 25%

Valuation Multiplesvs REIT - Healthcare Facilities median · lower = cheaper

P/E (12 months) 8.2× · Cheapest 25%
P/B 0.82× · Cheapest 25%
P/S (12 months) 2.65× · Cheapest 25%
EV/EBITDA 4.7× · Cheapest 25%
PEG 5.09× · Pricier than median

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)100 · sector 34
FUTURE (revenue growth)49 · sector 49
PAST (return on equity)42 · sector 31
HEALTH (low debt)100 · sector 74
DIVIDEND (yield)100 · sector 100

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more REIT - Healthcare Facilities stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
National Health Investors, Inc NHI $71.24 $90.17 +27% vs XRN
Omega Healthcare Investors, Inc OHI $48.19 $58.51 +21% vs XRN
Healthcare Realty Trust Incorporated HR $19.20 $20.82 +8% vs XRN
Sabra Health Care REIT, Inc SBRA $21.02 $22.18 +6% vs XRN
CareTrust REIT, Inc CTRE $38.21 $31.01 −19% vs XRN
Healthpeak Properties, Inc DOC $20.26 $16.07 −21% vs XRN
Aedifica NV AED €65.65 €51.37 −22% vs XRN
Ventas, Inc VTR $88.75 $33.27 −63% vs XRN
Welltower Inc WELL $245.01 $74.12 −70% vs XRN
American Healthcare REIT, Inc AHR $57.91 $12.01 −79% vs XRN

Explore undervalued stocks

More undervalued Real Estate stocks →

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Chiron Real Estate Inc.: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "Chiron Real Estate Inc. Fair Value". https://www.fairvalue-calculator.com/stock/XRN

Frequently asked questions

Is Chiron Real Estate Inc. (XRN) overvalued or undervalued?
As of Nov 7, 2026, our model estimates a fair value of $71.75 versus a price of $28.70, about +150% upside (undervalued).
What is the fair value of XRN?
Our model-based fair value for Chiron Real Estate Inc. is $71.75 (as of Nov 7, 2026), built from audited fundamentals. The current price: $28.70.
What is the quality score of XRN?
Chiron Real Estate Inc. has a Quality Score of 42/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Chiron Real Estate Inc. (XRN)?
Our model-based price target is the fair value of $71.75 (as of Nov 7, 2026) from 4 valuation models. Cautious scenario $44.01, optimistic scenario $99.49. It is a calculation from audited fundamentals, not an analyst target.
What is the Chiron Real Estate Inc. stock forecast for 2026?
Our models put fair value at $71.75, about +150% upside versus a price of $28.70 (undervalued). Cautious scenario $44.01, optimistic scenario $99.49. The calculation is refreshed regularly with new filings.
What is the revenue of Chiron Real Estate Inc. (XRN)?
Chiron Real Estate Inc. reported trailing-twelve-month revenue of about $157M (latest available figure, as of Nov 7, 2026).
Does Chiron Real Estate Inc. pay a dividend?
Chiron Real Estate Inc. currently shows a dividend yield of 7.00% relative to its recent price (as of Nov 7, 2026).
How much is the dividend of Chiron Real Estate Inc. (XRN) and when is the ex-dividend date?
Chiron Real Estate Inc. pays a dividend of $2.01 per share a year, a dividend yield of 7.0%. The next ex-dividend date is Nov 20, 2026, with payment on Dec 18, 2026. A dividend has been paid every year since at least 2014. The payout ratio is 57.4% of earnings. Our assessment: Watch coverage. The dividend isn’t fully covered by free cash flow or earnings, part of it is funded from reserves or debt. Fine for now, but worth watching: if it stays uncovered, the dividend could be cut.
What is the intrinsic value of Chiron Real Estate Inc. (XRN)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Chiron Real Estate Inc. it is $71.75 per share (as of Nov 7, 2026), against a price of $28.70. It is the blended result of 4 valuation models in 2 families (Multiples, Asset-Based).
Is Chiron Real Estate Inc. stock overvalued or undervalued in 2026?
As of Nov 7, 2026, XRN trades below its calculated fair value: price $28.70, fair value $71.75, a gap of about +150% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of XRN?
No. The price is what the market pays today ($28.70); the fair value is what the company's own numbers justify ($71.75). For Chiron Real Estate Inc. the two are $43.05 per share apart. That gap is exactly why we show both numbers side by side.
How much is Chiron Real Estate Inc. worth?
The market values Chiron Real Estate Inc. at about $416M (market capitalisation, as of Nov 7, 2026). Per share that is $28.70; our models calculate a fair value of $71.75 per share.
What do the bullish and bearish scenarios say about XRN?
Our models span a range for Chiron Real Estate Inc.: cautious scenario $44.01, base $71.75, optimistic $99.49 per share (as of Nov 7, 2026, price $28.70). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of XRN?
Chiron Real Estate Inc. trades at a price-to-earnings ratio of 8.2 (as of Nov 7, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of $71.75 is built from several models across several years. Other multiples: PEG 5.1, P/B 0.8, P/S 2.6, EV/EBITDA 4.7.
What is the PEG ratio of XRN?
The PEG ratio of Chiron Real Estate Inc. is 5.09 (P/E divided by earnings growth, as of Nov 7, 2026). That is above 1, so the growth is already paid for in the price.
How solid is the balance sheet of Chiron Real Estate Inc. (XRN)?
Balance-sheet figures for Chiron Real Estate Inc. (as of Nov 7, 2026): return on equity 10.5%, debt of 0.00 per unit of equity. They feed the Quality Score of 42/100, which measures business quality independently of the share price.
How far is XRN from its 52-week high?
Chiron Real Estate Inc. trades at $28.70, about 25% below its 52-week high of $38.10 and at the low of $28.70 (as of Nov 6, 2026). Distance from the high says nothing about value: that is what the fair value of $71.75 is for.
Which stocks are comparable to Chiron Real Estate Inc.?
From the same area (Real Estate) we also value Welltower Inc, Ventas, Inc, Omega Healthcare Investors, Inc, Healthpeak Properties, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Chiron Real Estate Inc. stock attractive at the current price?
The data as of Nov 7, 2026: price $28.70, calculated fair value $71.75 (+150%), Quality Score 42/100, from 4 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of XRN calculated?
We run Chiron Real Estate Inc. through 4 models from 2 families: Multiples, Asset-Based. Every model gets the same audited fundamentals; the fair value of $71.75 builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.3% above its aggregate fair value. Chiron Real Estate Inc. currently trades 60% below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Chiron Real Estate Inc. (XRN)?
The closing price on Nov 6, 2026 was $28.70. Our model-based fair value is $71.75, about +150% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Chiron Real Estate Inc. right now?
The large discount to fair value meets weak quality (42/100). That raises the risk this is a value trap rather than a bargain. The price is below even our cautious bear case ($44.01). The market is more pessimistic than our downside scenario. A fairly wide model range ($44.01 to $99.49) leaves room in how you read the outcome. As a real-estate business, asset- and dividend-based methods carry more weight here than a standard DCF.

Key figures of Chiron Real Estate Inc.

How large is the market capitalisation of Chiron Real Estate Inc. (XRN)?
The market capitalisation of Chiron Real Estate Inc. is $416M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Chiron Real Estate Inc. (XRN)?
The price-to-sales ratio of Chiron Real Estate Inc. is 2.65 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Chiron Real Estate Inc. (XRN)?
Earnings per share at Chiron Real Estate Inc. are $3.50 (price ÷ EPS = P/E 8.2). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Chiron Real Estate Inc. (XRN)?
The dividend yield of Chiron Real Estate Inc. is 7.0% (payout 57.4%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Chiron Real Estate Inc. (XRN)?
The net margin of Chiron Real Estate Inc. is 36.7% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Chiron Real Estate Inc. (XRN)?
The return on equity (ROE) of Chiron Real Estate Inc. is 10.5% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Chiron Real Estate Inc. (XRN)?
On an EBIT basis the return on assets of Chiron Real Estate Inc. is 3.1% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Chiron Real Estate Inc. (XRN)?
The operating margin of Chiron Real Estate Inc. is 6.9% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Chiron Real Estate Inc. (XRN)?
Revenue at Chiron Real Estate Inc. is growing +9.8% versus a year earlier (3y avg +5.5%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much free cash flow does Chiron Real Estate Inc. (XRN) generate?
The free cash flow of Chiron Real Estate Inc. is −$8.1M (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Chiron Real Estate Inc. (XRN) carry?
The net debt of Chiron Real Estate Inc. is $651M (fiscal year 2025). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch Chiron Real Estate Inc. in the live analysis

One click puts Chiron Real Estate Inc. on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.